# EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function

> **NCT00302497** · PHASE3 · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 50 (—)

## Conditions studied

- Kidney Transplant

## Interventions

- **DRUG:** basiliximab

## Key facts

- **NCT ID:** NCT00302497
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 50 (—)
- **Last updated:** 2007-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00302497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00302497, "EXTEND Protocol for Transplanted Patient to Evaluate Kidney Function". Retrieved via MORVS 2026-10-24 from https://api.morvs.ai/clinical/NCT00302497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*